A lyophilised peptide is not stable. It is slow.
We set out what the cycle does, in order, so that a reader can see which of its steps a rushed operation shortens first.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
The Supply Chain Dispatch
The route did not close because of a rule about peptides.
One of the suppliers the Journal tracks has suspended shipping to Saudi Arabia following a run of consignments detained at the border. No statement has been published; the suspension is visible only in the checkout process, which no longer accepts addresses in that market. We have written to ask whether it is permanent and whether affected customers are being refunded.
Transit times on the lane moved from a median of nine days to a median of 7. Phase-change cold packs of the type commonly used in this trade are typically specified for 72 to 120 hours depending on configuration and ambient profile, which puts a substantial fraction of these shipments outside specification for the majority of the journey.
Three of the twenty companies in the Journal’s dossier programme ship without any temperature indicator. On our own purchasing record, an unindicated parcel is not a parcel that stayed cold; it is a parcel about which nothing is known. Suppliers that require indicator evidence for a replacement claim while shipping no indicator have constructed an unfalsifiable position.
Peter Malinowski, former state board of pharmacy inspector, said the classification change would resolve itself. "These things always do, once the brokers learn the new code. The cost lands on whoever shipped in the first fortnight."
The Journal is collecting temperature-indicator readings from readers on this lane. Photographs of an indicator with a tracking number are usable; recollections are not.
We set out what the cycle does, in order, so that a reader can see which of its steps a rushed operation shortens first.
A blank certificate with the numbers left editable is an ordinary internal document. Its circulation as a finished record is the problem.
Follow the resin, not the catalogue.
The result is unremarkable. What the report omits is not.
A result on one vial generalises to a batch only if the vial was drawn in a way that makes it representative — and nobody records how it was drawn.
The interval between manufacture and analysis is the most under-read figure on the page, and the one most likely to matter by the time a vial is opened.